The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.
There are four major factors that are impacting the value creation in pharmaceutical industry:
Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases
Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.
The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.
Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.
Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.
Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.
Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.
Growth in Emerging Economies
The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.
Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.
There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.
Cold, Cough, and Sore Throat Remedies Market – Insights Common cold spread from person to person through various medium such as cough droplets, sneezes, and mucus in hand. Common factors that cause co... Read more
Sexual Health Market Insights Physical or psychological factors both can result into sexual dysfunction. In most cases issues with sexual health result from a combination of physical and psychological facto... Read more
Oxytocic Pharmaceuticals Market Oxytocic drugs used to stimulate uterine activity. It is also used to control bleeding after childbirth. It is injected into a muscle, or given as an infusion into a vein. Na... Read more
Tissue Glue and Bio-adhesive Sealants Market – Insights Tissue glue is used as an alternative method for wound closure that is painless, fast, and does not require a follow-up visit for removal. Tissue glue... Read more
Ambulatory Surgical Center Market – Insights Ambulatory Surgical Center (ASC), also known as outpatient surgery center or same day care center, is a healthcare facility that focuses on delivering same-day s... Read more
North America Scar Treatment Market – Insights Healing of damaged tissues or wounds may create marks on the skin. These marks are referred as scars. Burn injury or other trauma condition, including surgery ... Read more
Surface Plasmon Resonance Market – Insights Surface Plasmon Resonance (SPR) is a technique used to monitor label-free bimolecular interactions in real time. In this technique, one of the molecules is immobilized on metallic film. Metal... Read more
North America Toxicology Laboratories Market – Insights Toxicology testing is a science, which deals with the identification of poisons and controlled substances and their effect on the legal, clinical, and... Read more
Rest of the World Factor VIII Deficiency Treatment Market – A Significant Management for Hemophilia A Treatment Novel product launches by the market players in the factor VIII deficiency treatment is ... Read more
Middle East and Turkey Hemophilia Treatment Market Insights Hemophilia is treated with recombinant coagulation factor, plasma derived coagulation factor, antifibrinolytic agents, and desmopressin. Most of the patients with hemophilia p... Read more
Peptic Ulcer Drugs Market – Insights Peptic ulcers are open sores that develop on the inside lining of the stomach and the upper portion of the small intestine. There are two types of peptic ulcers that inc... Read more
U.S. Medical Foods Market – Insights Medical foods can be defined as specialized nutrient formulation to be consumed or administered enteral under the supervision of a healthcare practitioner. Medical f... Read more
Compounding Pharmacies Market — Insights A pharmacy that is operated by a licensed pharmacist, licensed physician or a person under the guidance of a licensed pharmacist is called compounding pharmacy.... Read more
U.S. Unfractionated Heparin Market – A Boon to Medical Arena Increasing number of people suffering from venous thromboembolism (VTE) is subsequently resulting in rising demand for heparin. For instance,... Read more
U.S. Contract Research Organization (CROs) Market – Increasing Number of Clinical Trials Leading Growth of the U.S. Contract Research Organization (CROs) Market A contract resear... Read more
Cytotoxic Drugs Contract Manufacturing Market – Market Insights Cytotoxic drugs are high potent drug products that has application in the treatment of cancer. Cytotoxic drugs contract manufacturing are ... Read more
Middle East and Turkey Immune Thrombocytopenic Purpura (ITP) Treatment Drugs Market – Insights Thrombocytopenia is a disorder in which a patient has low level of platelets in the blood. The major causes... Read more
Netherlands Compounding Pharmacies Market — Insights A pharmacy that is operated by a licensed pharmacist, licensed physician or a person under the guidance of a licensed pharmacist is called compoundin... Read more